Moraga, CA, United States of America

Jason Damiano


 

 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 37(Granted Patents)


Location History:

  • Emeryville, CA (US) (2011)
  • Moraga, CA (US) (2015)
  • Oakland, CA (US) (2018 - 2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Jason Damiano: A Pioneer in Antibody Drug Conjugates

Introduction

Jason Damiano, an accomplished inventor based in Moraga, California, has made significant strides in the field of biopharmaceuticals. With a total of four patents under his name, Damiano is particularly recognized for his innovative work with antibody drug conjugates aimed at treating cancer. His contributions not only advance medical science but also hold promise for improved patient outcomes.

Latest Patents

Among Jason Damiano's latest innovations are his patents related to antibody drug conjugates. These applications describe anti-P-cadherin antibodies and their antigen binding fragments. The inventions encapsulate methods for treating cancer using these antibodies and their conjugates, along with methodologies for creating these antibodies and using them as diagnostic agents. This groundbreaking work is pivotal in enhancing cancer treatment protocols.

Career Highlights

Throughout his career, Jason Damiano has worked with prestigious organizations, including Novartis AG and Xoma Technology Ltd. These experiences have enriched his expertise and provided a solid foundation for his inventive endeavors in the biopharmaceutical domain.

Collaborations

Jason has collaborated with accomplished professionals in his field, including Mohammad Luqman and Daniel H. Bedinger. These collaborations have fostered an environment of innovation and have enabled the development of cutting-edge solutions in cancer therapies.

Conclusion

Jason Damiano stands out as a notable inventor in biopharmaceuticals, particularly for his work on antibody drug conjugates aimed at combating cancer. With multiple patents to his name and a history of collaboration with industry leaders, Damiano continues to be a driving force in medical innovation, paving the way for advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…